Arcus Biosciences, Inc.
https://arcusbio.com/Biotechnology company developing cancer immunotherapies targeting the adenosine and other oncology pathways
Location: United States, Hayward
Total raised: $177M
Investors 4
| Date | Name | Website |
| - | Aisling Ca... | aislingcap... |
| - | The Column... | thecolumng... |
| - | Taiho Vent... | taihoventu... |
| - | GV | gv.com |
Funding Rounds 2
| Date | Series | Amount | Investors | Deal News |
| 13.11.2017 | Series C | $107M | GV | Arcus Bios... |
| 01.09.2016 | Series B | $70M | GV | Arcus Bios... |
Mentions in press and media 6
| Date | Title | Description | Category | Author | Source |
| 27.05.2019 | NYSE chang... | “We are providing an improve... | - | - | medcitynew... |
| 20.02.2018 | Term Sheet... | IT’S ALL RITE Good morning,... | - | - | fortune.co... |
| 13.11.2017 | Arcus Bios... | Additional therapies are neede... | - | - | medcitynew... |
| 13.11.2017 | Arcus Bios... | HAYWARD, Calif.–(BUSINESS WI... | - | - | aislingcap... |
| 05.09.2016 | Arcus Bios... | Taiho Ventures, LLC today anno... | - | - | citybizlis... |
| 01.09.2016 | Arcus Bios... | Arcus Biosciences, a Hayward, ... | USA | - | finsmes.co... |